Document is current
Any future updates will be listed below
-
Authors
Anyfanti, Panagiota https://orcid.org/0000-0002-5658-4629
Antza, Christina https://orcid.org/0000-0001-5164-7435
Tragiannidis, Konstantinos https://orcid.org/0009-0009-5764-1320
Belančić, Andrej https://orcid.org/0000-0001-7848-6600
Şener, Yusuf Ziya https://orcid.org/0000-0001-5151-5133
Faour, Andrea Katrin https://orcid.org/0009-0006-9039-0197
Ainatzoglou, Alexandra https://orcid.org/0000-0002-4502-5290
Angeloudi, Elena https://orcid.org/0000-0003-3492-7915
Chaida, Evangelia https://orcid.org/0009-0003-6854-3669
Dimitroulas, Theodoros https://orcid.org/0000-0002-0364-1642
Kotsis, Vasilios https://orcid.org/0000-0002-3755-8097
-
Funding
Funding for this research was provided by:
Aristotle University of Thessaloniki
- License Information
-
More Information
Article History
Received: 22 January 2026
Accepted: 15 March 2026
First Online: 1 April 2026
Declarations
:
: TD reports consultancy fees, speaker fees, honoraria, and advisory board participation from AbbVie, Amgen, Boehringer Ingelheim, GSK, Genesis Pharma, Janssen, Lilly, SOBI, UCB, and Pfizer. TD has also received non-financial support for meeting attendance from AbbVie, Genesis Pharma, Janssen, Elpen, Enorasis, UCB, and Pfizer.All other authors declare no competing interests related to this work.
: This study is a systematic review of previously published studies. Ethical approval was not required, as no new data were collected and no human participants or animals were directly involved.
: Informed consent is not applicable; the study is based exclusively on the analysis of data from published studies.
